 |
|
|
Important Notice: The Forum does not endorse any medical
product or therapy. ALL medications and supplements
should be taken ONLY under the supervision of a physician,
due to the possibility of side-effects, drug interactions,
etc.
|
Drug:
|
Divalproex Sodium
|
|
Clinical Trial ID:
|
NCT00306475
|
|
Mode of action:
|
Na channel modulator
|
|
Phase:
|
Phase 4
|
|
Company:
|
Vanderbilt
|
|
Note:
|
Add-on therapy; no effect on stable and partial responsive
schizophrenia patients
|
Glick ID, Bosch J, Casey DE. A double-blind randomized trial
of mood stabilizer augmentation using lamotrigine and
valproate for patients with schizophrenia who are stabilized
and partially responsive. J Clin Psychopharmacol . 2009 Jun
1 ; 29(3):267-71. Abstract
Basan A, Kissling W, Leucht S. Valproate as an adjunct to
antipsychotics for schizophrenia: a systematic review of
randomized trials. Schizophr Res . 2004 Sep 1 ; 70(1):33-7. Abstract
|
|
|
|
|
Text Size 
See our most recent Schizophrenia Bulletin theme Webinar: